Gamma Investing LLC Madrigal Pharmaceuticals, Inc. Transaction History
Gamma Investing LLC
- $1.58 Trillion
- Q2 2025
A detailed history of Gamma Investing LLC transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Gamma Investing LLC holds 42 shares of MDGL stock, worth $15,078. This represents 0.0% of its overall portfolio holdings.
Number of Shares
42
Previous 118
64.41%
Holding current value
$15,078
Previous $39.1 Million
67.48%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding MDGL
# of Institutions
363Shares Held
23.5MCall Options Held
955KPut Options Held
419K-
Janus Henderson Group PLC London, X02.19MShares$787 Million0.34% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.1MShares$754 Million39.89% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$716 Million9.27% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$709 Million7.8% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.88MShares$674 Million0.01% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $6.14B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...